Regulated information

Get easy access to all the information you need. The documentation center allows you to open, send by e-mail or download any document. Feel free to use the filters and add several documents to your basket.

15 publications

Name	Date	Type
SALES 1st quarter 2024: €134M The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products.	29/04/2024	Public releases
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).	24/04/2024	Public releases
ANNUAL RESULTS 2023 (slideshow) 01.2023 Highlights 02.2023 Consolidated financial statements 03.Strategy and outlook	20/03/2024	Annual Report
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) Essentials sales: €313m (+4.5% at constant exchange rates) Net income - Group share: €56m (10.5% of sales) EBITDA: €113m (21.3% of sales) Free cash-flow: €89m	20/03/2024	Public releases
Annual sales 2023: €529 million Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)	24/01/2024	Public releases
Third quarter revenues: €132 million	14/10/2021	Public releases
2021 first half results 2021 Half year results	29/07/2021	Public releases
Availability of the 2020 universal registration document Vetoquinol informs that it has filed its 2020 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 28th, 2021.	28/04/2021	Public releases
Q1 2021 sales Q1 2021 sales : €128M (up 28% at constant exchange rates, up 24% as reported) Q1 2021 essential sales : €72.6M (up 38% at constant exchange rates, up 36% as reported)	15/04/2021	Public releases
[VIDEO ]Présentation des résultats 2020 - french Présentation analystes & investisseurs - 1er avril 2021	01/04/2021	Annual Report